NYSEARCA:PSIL AdvisorShares Psychedelics ETF (PSIL) Price, Holdings, & News → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free PSIL Stock Alerts $1.29 +0.01 (+0.78%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$1.28▼$1.3050-Day Range$1.21▼$1.6952-Week Range$1.20▼$2.25Volume40,860 shsAverage Volume70,846 shsMarket Capitalization$7.25 millionAssets Under Management$7.00 millionDividend Yield3.88%Net Expense Ratio1.00% Stock AnalysisStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings Get AdvisorShares Psychedelics ETF alerts: Email Address About AdvisorShares Psychedelics ETF (NYSEARCA:PSIL)The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is managed by AdvisorShares.Read More PSIL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PSIL ETF News HeadlinesMay 2, 2024 | americanbankingnews.comAdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Stock Price Down 0.7%February 13, 2024 | thestreet.comAdvisorShares Psychedelics ETFMay 5, 2024 | Stansberry Research (Ad)Global crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...December 18, 2023 | markets.businessinsider.comPsyched: Biden's Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And MoreSeptember 11, 2023 | markets.businessinsider.comPsyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And MoreAugust 21, 2023 | benzinga.comPsyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly ReportsJuly 24, 2023 | benzinga.comPsyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & MoreJuly 15, 2023 | msn.comWatch these psychedelic stocks as sector faces year of 'collapse and consolidation'May 5, 2024 | Stansberry Research (Ad)Global crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...July 11, 2023 | markets.businessinsider.comPsyched: Australia's Innovative Program, Congressional Amendments, Therapy Reimbursement And MoreSee More Headlines Receive PSIL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AdvisorShares Psychedelics ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerAdvisorShares Fund NameAdvisorShares Psychedelics ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:PSIL Inception Date9/15/2021 Fund ManagerDan S. Ahrens WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings28 Fund Statistics Assets Under Management$7.00 million Average Daily Volume$0.00 Discount/Premium0.04% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorAdvisorShares Investments, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume100 Put Options90 Call Options10 Miscellaneous Outstanding Shares5,620,000Beta0.82 Creation Fee$500.00 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now AdvisorShares Psychedelics ETF ExpensesTypePSILTheme ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.60%0.57%0.54%0.50%0.51%Other Expenses2.51%0.72%0.54%0.64%0.58%Total Expense3.11%0.72%0.70%0.74%0.70%Fee Waiver-2.11%-0.76%-0.55%-0.69%-0.57%Net Expense1.00%0.59%0.60%0.58%0.58% AdvisorShares Psychedelics ETF (PSIL) Holdings & ExposureTop 10 PSIL HoldingsMind Medicine (MindMed)(NASDAQ:MNMD)Holding Weight: 14.76%Cybin Inc Ordinary SharesHolding Weight: 9.30%COMPASS Pathways(NASDAQ:CMPS)Holding Weight: 6.93%Atai Life Sciences(NASDAQ:ATAI)Holding Weight: 5.43%Vistagen Therapeutics(NASDAQ:VTGN)Holding Weight: 5.42%GH Research(NASDAQ:GHRS)Holding Weight: 5.32%Intra-Cellular Therapies(NASDAQ:ITCI)Holding Weight: 5.28%BlackRock Liquidity Treasury InstlHolding Weight: 4.80%NRx Pharmaceuticals(NASDAQ:NRXP)Holding Weight: 4.75%Alkermes(NASDAQ:ALKS)Holding Weight: 4.73%PSIL Sector ExposurePSIL Industry ExposureFull Holdings Details Similar ETFsGlobal X Disruptive Materials ETFNASDAQ:DMATiShares Future Cloud 5G and Tech ETFNYSEARCA:IDATIQ Engender Equality ETFNYSEARCA:EQULAdvisorShares Vice ETFNYSEARCA:VICEBlackRock Future U.S. Themes ETFNYSEARCA:BTHMInstitutional OwnershipSpire Wealth ManagementBought 18,000 shares on 4/24/2024Ownership: 0.773%Spire Wealth ManagementBought 14,000 shares on 2/6/2024Ownership: 0.575%View All Institutional Transactions PSIL ETF - Frequently Asked Questions How have PSIL shares performed in 2024? AdvisorShares Psychedelics ETF's stock was trading at $1.39 on January 1st, 2024. Since then, PSIL stock has decreased by 7.2% and is now trading at $1.29. View the best growth stocks for 2024 here. What does PSIL invest in? AdvisorShares Psychedelics ETF is a equity fund issued by AdvisorShares. PSIL focuses on theme investments. The fund's investments total to approximately $7.00 million assets under management. What stocks does AdvisorShares Psychedelics ETF hold? PSIL invests in 28 holdings. Some of the stocks in their portfolio include Mind Medicine (MindMed) (MNMD), COMPASS Pathways (CMPS), Atai Life Sciences (ATAI), Vistagen Therapeutics (VTGN), GH Research (GHRS), Intra-Cellular Therapies (ITCI), NRx Pharmaceuticals (NRXP), Alkermes (ALKS), Relmada Therapeutics (RLMD) and Enveric Biosciences (ENVB). What is the management fee for AdvisorShares Psychedelics ETF? AdvisorShares Psychedelics ETF's management fee is 0.60% and has other expenses of 2.51%. However, PSIL has a fee waiver of -2.11% to reimburse the expenses. The net expense ratio for PSIL is 1.00%. Who are AdvisorShares Psychedelics ETF's major shareholders? AdvisorShares Psychedelics ETF's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Spire Wealth Management (0.77%). How do I buy shares of AdvisorShares Psychedelics ETF? Shares of PSIL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:PSIL) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe only AI company you should be looking atBehind the MarketsWarren Buffet Stockpiling Gold?Reagan Gold GroupDid You Get Your Free Bitcoin Yet?Crypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdvisorShares Psychedelics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
